Author
Toscana Life SciencesORCID 0000-0002-3564-9112Unclaimed ORCID profile · follow to get notified of new preprints
6 papers
Recent·Most cited
Denise Guerra, Edoardo Cherubini, Mabel RM Echague…·Emanuele Andreano
This study isolates and characterizes monoclonal antibodies against Toscana virus's Gc glycoprotein, identifying cross-reactive antibodies that protect against Rift Valley Fever Virus.
Ida Paciello, Ling Zhou, Emily J. Rundlet…·Emanuele Andreano
The paper identifies OPG153 as a target of broadly neutralizing antibodies against MPXV and related viruses using antigen-agnostic isolation, AlphaFold 3 modeling, and cryo-EM.
Emanuele Roscioli, Vittoria Zucconi Galli Fonseca, Soraya Soledad Bosch…·Rino Rappuoli
This study isolates human monoclonal antibodies against hypervirulent, pandrug-resistant Klebsiella pneumoniae and identifies capsule-specific antibodies as protective against bloodstream infection.
Marco Troisi, Monica Fabbrini, Samuele Stazzoni…·Rino Rappuoli
The paper identifies human monoclonal antibodies that recognize key antigens, PorB and LOS, providing cross-protection against gonococcal and meningococcal infections.
Nicole V. Johnson, Steven C. Wall, Kevin J. Kramer…·Ivelin S. Georgiev
The paper identifies a pan-betacoronavirus antibody that binds the S2 subunit of spike proteins and induces Fc-dependent antiviral responses, offering insights into non-neutralizing antibody protection.
Ida Paciello, Giulio Pierleoni, Elisa Pantano…·Emanuele Andreano
The paper analyzes neutralizing antibodies from vaccinated and hybrid immune individuals to show that restored B cell germlines enhance neutralization against SARS-CoV-2 variants like BA.2.86.